Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice
Analysis
How the regulatory, payments and operating environment actually behaves for businesses in this sector — and which parts of it are within an operator's control.
Business & operations
The hard parts of this business are not the ones most people plan for. Sourcing, documentation, payments and claim discipline determine whether an operation survives — the storefront is the easy half.
3 Sept 2026 · 11 min
Business & operations
Payment access is the most common single point of failure for peptide merchants. The underwriting logic is not arbitrary, and understanding what it is actually measuring makes most of the outcome controllable.
3 Sept 2026 · 8 min
Intelligence pieces are published when there is something specific and sourceable to say. Therapept does not maintain a payment processor directory: policies in this category change often enough that a published list would be misleading within months, and a stale recommendation there is worse than none.
